Keyphrases
Glioblastoma
75%
Tumor
66%
Triple-negative Breast Cancer
53%
Breast Cancer
49%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
47%
Neoadjuvant
41%
Overall Survival
39%
Postmenopausal Women
38%
Patient-derived Xenograft
37%
Alzheimer's Disease
35%
Breast Cancer Patients
29%
Gene Signature
28%
Palbociclib
27%
Clinical Trials
26%
Confidence Interval
26%
Prostate Cancer
25%
Clinical Outcomes
24%
Tumor Progression
24%
Alzheimer's Disease Biomarkers
24%
High-risk Human Papillomavirus (HR-HPV)
23%
ACK1
22%
Estrogen Receptor-positive Breast Cancer
21%
Sex Differences
21%
Phase II Study
21%
Androgen Receptor
21%
Gene Expression
21%
Ki-67
20%
Chemotherapy
19%
Pancreatic Ductal Adenocarcinoma
19%
White People
18%
Letrozole
18%
Estrogen
17%
Cancer Cells
17%
Hazard Ratio
17%
Mammographic Breast Density
17%
In Cancer
16%
Acetylation
16%
Cyclin-dependent Kinase 4 (CDK4)
16%
Racial Differences
16%
Estrogen Receptor
16%
Prognostic Marker
15%
Acute Myeloid Leukemia
15%
Endocrine Therapy
15%
Diagnostic Accuracy
15%
Prognostic Effect
15%
Pancreatic Cancer
15%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
15%
Androgen Production
14%
Early Diagnosis
14%
Multinucleation
14%
Medicine and Dentistry
Neoplasm
100%
Breast Cancer
97%
Biological Marker
52%
Overall Survival
51%
Oropharynx Squamous Cell Carcinoma
48%
Glioblastoma
40%
Triple Negative Breast Cancer
38%
Malignant Neoplasm
37%
Diseases
31%
Tumor Progression
26%
Clinical Trial
25%
Recurrent Disease
25%
Magnetic Resonance Imaging
24%
Premenopause
24%
Cancer
23%
Palbociclib
23%
Wart Virus
22%
P16
22%
microRNA
19%
Prostate Cancer
18%
Aromatase Inhibitor
18%
Breast Density
17%
Gene Expression
17%
Hazard Ratio
17%
Androgen Receptor
15%
Estrogen Receptor
15%
Pancreas Adenocarcinoma
15%
Cancer Cell
14%
Soft Tissue Sarcoma
14%
Ganglioglioma
14%
Aquaporin 1
14%
Diffuse Large B-Cell Lymphoma
14%
Xenograft
13%
Metastatic Breast Cancer
13%
Estrogen Receptor Positive Breast Cancer
12%
Metastatic Carcinoma
12%
Tumor Cell
12%
Hormone Therapy
12%
Myeloid Cell
12%
Anastrozole
12%
Macrophage
12%
Progression Free Survival
12%
Temozolomide
12%
Cerebrospinal Fluid
12%
Clear Cell Renal Cell Carcinoma
12%
Ovarian Cancer
11%
Lymphocyte
11%
Protein Expression
11%
Breast Biopsy
11%
Positron Emission Tomography
11%